Dongyi Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dongyi Xu has a total of 250 co-authors. Here are the top co-authors by number of shared publications:
- Weidong Wang
Laboratory of Genetics and Genomics, National Institute on Aging, Baltimore, Maryland, USA
11 shared publications Rong Guo
State Key Laboratory of Gene Function and Modulation Research, School of Life Sciences, Peking University , Beijing 100871
9 shared publications- Rong Guo
State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China
9 shared publications Shaokai Ning
State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University, Beijing, China
7 shared publicationsWen Li
Peking University
5 shared publicationsYutong Xue
5 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Springer Nature in Cell Death & Disease
Folate stress as a contributing factor to Fanconi anemia
Fanconi anemia (FA) is a rare chromosomal instability disorder characterized by progressive bone marrow failure, congenital abnormalities, and a heightened cancer predisposition. With at least 23 identified FA genes, biallelic mutations in any one of these genes disrupt the FA pathway, a specialized DNA repair mechanism, leading to disease pathogenesis. FA cells are hypersensitive to DNA interstrand crosslinks (ICLs), which have been linked to endogenous aldehydes and oxidative stress, both contributing factors to FA pathogenesis. Our previous work identified replication stress as a significant driver of FA pathology, demonstrating that FA-deficient cells are particularly vulnerable to persistent replication stress. Here, we reveal that folate deficiency, a condition impairing DNA synthesis, repair, and methylation, constitutes a previously unrecognized contributing factor to FA. We show that folate stress causes aberrant DNA replication in FA-deficient cells, leading to chromosomal loss and proliferation delay. Mechanistically, the FA pathway is activated under folate stress and engages a break-induced replication (BIR)-like process to mitigate replication-associated damage. Importantly, feeding Fancl -/- mice a folate-deficient diet induced bone marrow failure, recapitulating a hallmark FA symptom. Our findings suggest that folate supplementation may offer a potential strategy for ameliorating FA symptoms.
- 2 November 2026
- Published by Springer Nature in Cell Death & Disease
Open AccessFolate stress as a contributing factor to Fanconi anemia
Fanconi anemia (FA) is a rare chromosomal instability disorder characterized by progressive bone marrow failure, congenital abnormalities, and a heightened cancer predisposition. With at least 23 identified FA genes, biallelic mutations in any one of these genes disrupt the FA pathway, a specialized DNA repair mechanism, leading to disease pathogenesis. FA cells are hypersensitive to DNA interstrand crosslinks (ICLs), which have been linked to endogenous aldehydes and oxidative stress, both contributing factors to FA pathogenesis. Our previous work identified replication stress as a significant driver of FA pathology, demonstrating that FA-deficient cells are particularly vulnerable to persistent replication stress. Here, we reveal that folate deficiency, a condition impairing DNA synthesis, repair, and methylation, constitutes a previously unrecognized contributing factor to FA. We show that folate stress causes aberrant DNA replication in FA-deficient cells, leading to chromosomal loss and proliferation delay. Mechanistically, the FA pathway is activated under folate stress and engages a break-induced replication (BIR)-like process to mitigate replication-associated damage. Importantly, feeding Fancl -/- mice a folate-deficient diet induced bone marrow failure, recapitulating a hallmark FA symptom. Our findings suggest that folate supplementation may offer a potential strategy for ameliorating FA symptoms.
- Open Access
- 22 January 2026
- Published by Springer Nature in Research Square
Folate stress as a Contributing Factor to Fanconi Anemia
Fanconi Anemia (FA) is a rare chromosomal instability disorder characterized by progressive bone marrow failure, congenital abnormalities, and a heightened cancer predisposition. With at least 22 identified FA genes, biallelic mutations in any one of these genes disrupt the FA pathway, a specialized DNA repair mechanism, leading to disease pathogenesis. FA cells are hypersensitive to DNA interstrand crosslinks (ICLs), which have been linked to endogenous aldehydes and oxidative stress, both contributing factors to FA pathogenesis. Our previous work identified replication stress as a significant driver of FA pathology, demonstrating that FA-deficient cells are particularly vulnerable to persistent replication stress. Here, we reveal that folate deficiency, a condition impairing DNA synthesis, repair, and methylation, constitutes a previously unrecognized contributing factor to FA. We show that folate stress causes aberrant DNA replication in FA-deficient cells, leading to chromosomal loss and proliferation delay. Mechanistically, the FA pathway is activated under folate stress and engages a break-induced replication (BIR)-like process to mitigate replication-associated damage. Importantly, feeding Fancl −/− mice a folate-deficient diet induced bone marrow failure, recapitulating a hallmark FA symptom. Our findings suggest that folate supplementation may offer a potential strategy for ameliorating FA symptoms.
- 22 January 2026
- Published by Springer Nature in Research Square
Open AccessFolate stress as a Contributing Factor to Fanconi Anemia
Fanconi Anemia (FA) is a rare chromosomal instability disorder characterized by progressive bone marrow failure, congenital abnormalities, and a heightened cancer predisposition. With at least 22 identified FA genes, biallelic mutations in any one of these genes disrupt the FA pathway, a specialized DNA repair mechanism, leading to disease pathogenesis. FA cells are hypersensitive to DNA interstrand crosslinks (ICLs), which have been linked to endogenous aldehydes and oxidative stress, both contributing factors to FA pathogenesis. Our previous work identified replication stress as a significant driver of FA pathology, demonstrating that FA-deficient cells are particularly vulnerable to persistent replication stress. Here, we reveal that folate deficiency, a condition impairing DNA synthesis, repair, and methylation, constitutes a previously unrecognized contributing factor to FA. We show that folate stress causes aberrant DNA replication in FA-deficient cells, leading to chromosomal loss and proliferation delay. Mechanistically, the FA pathway is activated under folate stress and engages a break-induced replication (BIR)-like process to mitigate replication-associated damage. Importantly, feeding Fancl −/− mice a folate-deficient diet induced bone marrow failure, recapitulating a hallmark FA symptom. Our findings suggest that folate supplementation may offer a potential strategy for ameliorating FA symptoms.
- Open Access
- 26 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (22)
A nucleoskeleton network preserves genomic integrity by promoting NHEJ and restraining chromosome translocations
Chromosomal translocation (CT) is characterized by incorrect ligation between chromosome fragments when multiple DNA double-strand breaks (DSBs) exist simultaneously. DNA repair, the three-dimensional structure of the nucleoskeleton, and the spatial and temporal movement of DSB ends contribute to CTs. Our earlier research showed that Intermediate Filament Family Orphan 1 (IFFO1) links the nucleoskeleton and non-homologous end joining (NHEJ) to prevent CTs. In this study, we identified the paralog IFFO2, which, together with IFFO1, forms a complex interaction network. We demonstrate that the C-terminus of these IFFOs binds to XRCC4 to facilitate its participation in the NHEJ process. In contrast, their N-termini oversee the building of the nucleoskeleton by connecting with each other and Lamin A/C. Interestingly, IFFO1 and IFFO2 show epistatic effects in suppressing CT by anchoring broken DNA ends and have non-epistatic roles in NHEJ-mediated DSB repair. Our results define an integrated nucleoskeleton composed of IFFO1–IFFO2–Lamin A/C, and reveal its dual functions in genome stability maintenance, the promotion of end-joining, and the suppression of CT.
- 26 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (22)
Open AccessA nucleoskeleton network preserves genomic integrity by promoting NHEJ and restraining chromosome translocations
Chromosomal translocation (CT) is characterized by incorrect ligation between chromosome fragments when multiple DNA double-strand breaks (DSBs) exist simultaneously. DNA repair, the three-dimensional structure of the nucleoskeleton, and the spatial and temporal movement of DSB ends contribute to CTs. Our earlier research showed that Intermediate Filament Family Orphan 1 (IFFO1) links the nucleoskeleton and non-homologous end joining (NHEJ) to prevent CTs. In this study, we identified the paralog IFFO2, which, together with IFFO1, forms a complex interaction network. We demonstrate that the C-terminus of these IFFOs binds to XRCC4 to facilitate its participation in the NHEJ process. In contrast, their N-termini oversee the building of the nucleoskeleton by connecting with each other and Lamin A/C. Interestingly, IFFO1 and IFFO2 show epistatic effects in suppressing CT by anchoring broken DNA ends and have non-epistatic roles in NHEJ-mediated DSB repair. Our results define an integrated nucleoskeleton composed of IFFO1–IFFO2–Lamin A/C, and reveal its dual functions in genome stability maintenance, the promotion of end-joining, and the suppression of CT.
- 1 August 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (8) , 1474-1491
Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension
Rationale: Clinical observations have suggested an association between alkylating agent–based chemotherapy and pulmonary arterial hypertension (PAH). The Fanconi anemia (FA) pathway, the principal mechanism for resolving alkylating agent–induced DNA damage, has been implicated in this process. Objectives: To establish the interplay among the FA pathway, DNA damage, and PAH. Methods: A knockout-first mouse model for FA complementation group L (Fanclkf/kf) and an adenovirus-associated virus 9–mediated Fancl overexpression (AAV-Fancl) model were used. Lung specimens, pulmonary arterial endothelial cells from patients with PAH, and primarily cultured pulmonary microvascular endothelial cells (PMVECs) from wild-type and Fanclkf/kf mice were analyzed. Measurements and Main Results: Data analysis on lung single-cell RNA-sequencing datasets revealed significant downregulation of FANCL in endothelial cells from patients with idiopathic PAH, a finding consistently validated in both clinical samples (lung specimens and pulmonary arterial endothelial cells) and the monocrotaline-induced PAH rat model. Notably, Fanclkf/kf mice developed spontaneous PAH and showed heightened susceptibility to alkylating agent (mitomycin C)-induced PAH, characterized by severe DNA damage and apoptosis in PMVECs. These pathological phenotypes were rescued through Fancl gene supplementation via AAV-Fancl or pharmacological intervention with the DNA damage protector amifostine. Mechanistically, transcriptomic profiling combined with functional validation demonstrated a suppressed bone morphogenetic protein signaling coupled with hyperactivated transforming growth factor-β pathways in PMVECs from Fanclkf/kf mice. Importantly, this imbalance was fully restored in PMVECs from AAV-Fancl–treated mice. Conclusions: Deficient Fancl plays a key role to promote PAH, and targeted rescue of Fancl could be a novel effective strategy for the treatment of PAH.
- 1 August 2025
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 211 (8) , 1474-1491
Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension
Rationale: Clinical observations have suggested an association between alkylating agent–based chemotherapy and pulmonary arterial hypertension (PAH). The Fanconi anemia (FA) pathway, the principal mechanism for resolving alkylating agent–induced DNA damage, has been implicated in this process. Objectives: To establish the interplay among the FA pathway, DNA damage, and PAH. Methods: A knockout-first mouse model for FA complementation group L (Fanclkf/kf) and an adenovirus-associated virus 9–mediated Fancl overexpression (AAV-Fancl) model were used. Lung specimens, pulmonary arterial endothelial cells from patients with PAH, and primarily cultured pulmonary microvascular endothelial cells (PMVECs) from wild-type and Fanclkf/kf mice were analyzed. Measurements and Main Results: Data analysis on lung single-cell RNA-sequencing datasets revealed significant downregulation of FANCL in endothelial cells from patients with idiopathic PAH, a finding consistently validated in both clinical samples (lung specimens and pulmonary arterial endothelial cells) and the monocrotaline-induced PAH rat model. Notably, Fanclkf/kf mice developed spontaneous PAH and showed heightened susceptibility to alkylating agent (mitomycin C)-induced PAH, characterized by severe DNA damage and apoptosis in PMVECs. These pathological phenotypes were rescued through Fancl gene supplementation via AAV-Fancl or pharmacological intervention with the DNA damage protector amifostine. Mechanistically, transcriptomic profiling combined with functional validation demonstrated a suppressed bone morphogenetic protein signaling coupled with hyperactivated transforming growth factor-β pathways in PMVECs from Fanclkf/kf mice. Importantly, this imbalance was fully restored in PMVECs from AAV-Fancl–treated mice. Conclusions: Deficient Fancl plays a key role to promote PAH, and targeted rescue of Fancl could be a novel effective strategy for the treatment of PAH.
- Open Access
- 3 August 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Structural and mechanistic insights into the MCM8/9 helicase complex
MCM8 and MCM9 form a functional helicase complex (MCM8/9) that plays an essential role in DNA homologous recombination repair for DNA double-strand break. However, the structural characterization of MCM8/9 for DNA binding/unwinding remains unclear. Here, we report structures of the MCM8/9 complex using cryo-electron microscopy single particle analysis. The structures reveal that MCM8/9 is arranged into a heterohexamer through a threefold symmetry axis, creating a central channel that accommodates DNA. Multiple characteristic hairpins from the N-terminal oligosaccharide/oligonucleotide (OB) domains of MCM8/9 protrude into the central channel and serve to unwind the duplex DNA. When activated by HROB, the structure of MCM8/9’s N-tier ring converts its symmetry from C3 to C1 with a conformational change that expands the MCM8/9’s trimer interface. Moreover, our structural dynamic analyses revealed that the flexible C-tier ring exhibited rotary motions relative to the N-tier ring, which is required for the unwinding ability of MCM8/9. In summary, our structural and biochemistry study provides a basis for understanding the DNA unwinding mechanism of MCM8/9 helicase in homologous recombination.
- 3 August 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Open AccessStructural and mechanistic insights into the MCM8/9 helicase complex
MCM8 and MCM9 form a functional helicase complex (MCM8/9) that plays an essential role in DNA homologous recombination repair for DNA double-strand break. However, the structural characterization of MCM8/9 for DNA binding/unwinding remains unclear. Here, we report structures of the MCM8/9 complex using cryo-electron microscopy single particle analysis. The structures reveal that MCM8/9 is arranged into a heterohexamer through a threefold symmetry axis, creating a central channel that accommodates DNA. Multiple characteristic hairpins from the N-terminal oligosaccharide/oligonucleotide (OB) domains of MCM8/9 protrude into the central channel and serve to unwind the duplex DNA. When activated by HROB, the structure of MCM8/9’s N-tier ring converts its symmetry from C3 to C1 with a conformational change that expands the MCM8/9’s trimer interface. Moreover, our structural dynamic analyses revealed that the flexible C-tier ring exhibited rotary motions relative to the N-tier ring, which is required for the unwinding ability of MCM8/9. In summary, our structural and biochemistry study provides a basis for understanding the DNA unwinding mechanism of MCM8/9 helicase in homologous recombination.
- Open Access
- 19 July 2023
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
Structural and mechanistic insights into the MCM8/9 helicase complex
MCM8 and MCM9 form a functional helicase complex (MCM8/9) that plays an essential role in DNA homologous recombination repair for DNA double-strand break. However, the structural characterization of MCM8/9 for DNA binding/unwinding remains unclear. Here, we report structures of the MCM8/9 complex using cryo-electron microscopy single particle analysis. The structures reveal that MCM8/9 is arranged into a heterohexamer through a three-fold symmetry axis, creating a central channel that accommodates DNA. Multiple characteristic hairpins from the N-terminal oligosaccharide/oligonucleotide (OB) domains of MCM8/9 protrude into the central channel and serve to unwind the duplex DNA. When activated by HROB, the structure of MCM8/9’s N-tier ring converts its symmetry from C3 to C1 with a conformational change that expands the MCM8/9’s trimer interface. Moreover, our structural dynamic analyses revealed that the flexible C-tier ring exhibited rotary motions relative to the N-tier ring, which is required for the unwinding ability of MCM8/9. In summary, our structural and biochemistry study provide a basis for understanding the DNA unwinding mechanism of MCM8/9 helicase in homologous recombination.
- 19 July 2023
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 12
Open AccessStructural and mechanistic insights into the MCM8/9 helicase complex
MCM8 and MCM9 form a functional helicase complex (MCM8/9) that plays an essential role in DNA homologous recombination repair for DNA double-strand break. However, the structural characterization of MCM8/9 for DNA binding/unwinding remains unclear. Here, we report structures of the MCM8/9 complex using cryo-electron microscopy single particle analysis. The structures reveal that MCM8/9 is arranged into a heterohexamer through a three-fold symmetry axis, creating a central channel that accommodates DNA. Multiple characteristic hairpins from the N-terminal oligosaccharide/oligonucleotide (OB) domains of MCM8/9 protrude into the central channel and serve to unwind the duplex DNA. When activated by HROB, the structure of MCM8/9’s N-tier ring converts its symmetry from C3 to C1 with a conformational change that expands the MCM8/9’s trimer interface. Moreover, our structural dynamic analyses revealed that the flexible C-tier ring exhibited rotary motions relative to the N-tier ring, which is required for the unwinding ability of MCM8/9. In summary, our structural and biochemistry study provide a basis for understanding the DNA unwinding mechanism of MCM8/9 helicase in homologous recombination.
- Open Access
- 6 September 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (37)
Epstein-Barr virus protein BKRF4 restricts nucleosome assembly to suppress host antiviral responses
Inhibition of host DNA damage response (DDR) is a common mechanism used by viruses to manipulate host cellular machinery and orchestrate viral life cycles. Epstein-Barr virus tegument protein BKRF4 associates with cellular chromatin to suppress host DDR signaling, but the underlying mechanism remains elusive. Here, we identify a BKRF4 histone binding domain (residues 15–102, termed BKRF4-HBD) that can accumulate at the DNA damage sites to disrupt 53BP1 foci formation. The high-resolution structure of the BKRF4-HBD in complex with a human H2A–H2B dimer shows that BKRF4-HBD interacts with the H2A–H2B dimer via the N-terminal region (NTR), the DWP motif (residues 80–86 containing D81, W84, P86), and the C-terminal region (CTR). The “triple-anchor” binding mode confers BKRF4-HBD the ability to associate with the partially unfolded nucleosomes, promoting the nucleosome disassembly. Importantly, disrupting the BKRF4–H2A–H2B interaction impairs the binding between BKRF4-HBD and nucleosome in vitro and inhibits the recruitment of BKRF4-HBD to DNA breaks in vivo. Together, our study reveals the structural basis of BKRF4 bindings to the partially unfolded nucleosome and elucidates an unconventional mechanism of host DDR signal attenuation.
- 6 September 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (37)
Open AccessEpstein-Barr virus protein BKRF4 restricts nucleosome assembly to suppress host antiviral responses
Inhibition of host DNA damage response (DDR) is a common mechanism used by viruses to manipulate host cellular machinery and orchestrate viral life cycles. Epstein-Barr virus tegument protein BKRF4 associates with cellular chromatin to suppress host DDR signaling, but the underlying mechanism remains elusive. Here, we identify a BKRF4 histone binding domain (residues 15–102, termed BKRF4-HBD) that can accumulate at the DNA damage sites to disrupt 53BP1 foci formation. The high-resolution structure of the BKRF4-HBD in complex with a human H2A–H2B dimer shows that BKRF4-HBD interacts with the H2A–H2B dimer via the N-terminal region (NTR), the DWP motif (residues 80–86 containing D81, W84, P86), and the C-terminal region (CTR). The “triple-anchor” binding mode confers BKRF4-HBD the ability to associate with the partially unfolded nucleosomes, promoting the nucleosome disassembly. Importantly, disrupting the BKRF4–H2A–H2B interaction impairs the binding between BKRF4-HBD and nucleosome in vitro and inhibits the recruitment of BKRF4-HBD to DNA breaks in vivo. Together, our study reveals the structural basis of BKRF4 bindings to the partially unfolded nucleosome and elucidates an unconventional mechanism of host DDR signal attenuation.
- Open Access
- 25 March 2022
- Published by Springer Nature in Research Square
A dual-activity topoisomerase complex regulates translation and abundance of mRNAs important for psychiatric disorders
Topoisomerase 3b (TOP3B)-TDRD3 is a dual-activity topoisomerase complex in animals that can change topology for both DNA and RNA. A current hypothesis proposes that this complex interacts with Fragile X mental retardation protein, FMRP, to regulate mRNA translation. Here we examined this hypothesis by identifying TOP3B-TDRD3-bound mRNAs in human HCT116 cells; and analyzing the effect of inactivating TOP3B, TOP3B catalytic activity, TDRD3, and FMRP, on translation and abundance of these mRNAs. We found that TOP3B-TDRD3 resembles FMRP in preferentially binding to coding regions of long mRNAs. Complete inactivation of TOP3B protein, but not a point mutation that only disrupts TOP3B catalytic activity, preferentially reduced the abundance of the TOP3B-TDRD3-bound mRNAs. Moreover, ablation of the complex or inactivation of TOP3B catalytic activity alters translation for some but not all TOP3B-TDRD3 bound mRNAs, suggesting that TOP3B-TDRD3 may solve topological problems for specific mRNAs. Finally, several schizophrenia and autism-risk genes are bound and regulated by TOP3B-TDRD3 in mRNA translation and abundance by topoisomerase activity dependent and independent manners. Our data suggest that TOP3B-TDRD3 can regulate mRNA translation and abundance by topoisomerase activity dependent or independent mechanisms; and disruption of this function could contribute to pathogenesis of psychiatric disorders in TOP3B mutation carriers.
- 25 March 2022
- Published by Springer Nature in Research Square
Open AccessA dual-activity topoisomerase complex regulates translation and abundance of mRNAs important for psychiatric disorders
Topoisomerase 3b (TOP3B)-TDRD3 is a dual-activity topoisomerase complex in animals that can change topology for both DNA and RNA. A current hypothesis proposes that this complex interacts with Fragile X mental retardation protein, FMRP, to regulate mRNA translation. Here we examined this hypothesis by identifying TOP3B-TDRD3-bound mRNAs in human HCT116 cells; and analyzing the effect of inactivating TOP3B, TOP3B catalytic activity, TDRD3, and FMRP, on translation and abundance of these mRNAs. We found that TOP3B-TDRD3 resembles FMRP in preferentially binding to coding regions of long mRNAs. Complete inactivation of TOP3B protein, but not a point mutation that only disrupts TOP3B catalytic activity, preferentially reduced the abundance of the TOP3B-TDRD3-bound mRNAs. Moreover, ablation of the complex or inactivation of TOP3B catalytic activity alters translation for some but not all TOP3B-TDRD3 bound mRNAs, suggesting that TOP3B-TDRD3 may solve topological problems for specific mRNAs. Finally, several schizophrenia and autism-risk genes are bound and regulated by TOP3B-TDRD3 in mRNA translation and abundance by topoisomerase activity dependent and independent manners. Our data suggest that TOP3B-TDRD3 can regulate mRNA translation and abundance by topoisomerase activity dependent or independent mechanisms; and disruption of this function could contribute to pathogenesis of psychiatric disorders in TOP3B mutation carriers.
- Open Access
- 17 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
RIF1-ASF1-mediated high-order chromatin structure safeguards genome integrity
The 53BP1-RIF1 pathway antagonizes resection of DNA broken ends and confers PARP inhibitor sensitivity on BRCA1-mutated tumors. However, it is unclear how this pathway suppresses initiation of resection. Here, we identify ASF1 as a partner of RIF1 via an interacting manner similar to its interactions with histone chaperones CAF-1 and HIRA. ASF1 is recruited to distal chromatin flanking DNA breaks by 53BP1-RIF1 and promotes non-homologous end joining (NHEJ) using its histone chaperone activity. Epistasis analysis shows that ASF1 acts in the same NHEJ pathway as RIF1, but via a parallel pathway with the shieldin complex, which suppresses resection after initiation. Moreover, defects in end resection and homologous recombination (HR) in BRCA1-deficient cells are largely suppressed by ASF1 deficiency. Mechanistically, ASF1 compacts adjacent chromatin by heterochromatinization to protect broken DNA ends from BRCA1-mediated resection. Taken together, our findings identify a RIF1-ASF1 histone chaperone complex that promotes changes in high-order chromatin structure to stimulate the NHEJ pathway for DSB repair.
- 17 February 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Open AccessRIF1-ASF1-mediated high-order chromatin structure safeguards genome integrity
The 53BP1-RIF1 pathway antagonizes resection of DNA broken ends and confers PARP inhibitor sensitivity on BRCA1-mutated tumors. However, it is unclear how this pathway suppresses initiation of resection. Here, we identify ASF1 as a partner of RIF1 via an interacting manner similar to its interactions with histone chaperones CAF-1 and HIRA. ASF1 is recruited to distal chromatin flanking DNA breaks by 53BP1-RIF1 and promotes non-homologous end joining (NHEJ) using its histone chaperone activity. Epistasis analysis shows that ASF1 acts in the same NHEJ pathway as RIF1, but via a parallel pathway with the shieldin complex, which suppresses resection after initiation. Moreover, defects in end resection and homologous recombination (HR) in BRCA1-deficient cells are largely suppressed by ASF1 deficiency. Mechanistically, ASF1 compacts adjacent chromatin by heterochromatinization to protect broken DNA ends from BRCA1-mediated resection. Taken together, our findings identify a RIF1-ASF1 histone chaperone complex that promotes changes in high-order chromatin structure to stimulate the NHEJ pathway for DSB repair.
- Open Access
Structural and mechanistic insights into the MCM8/9 helicase complex
MCM8 and MCM9 form a functional helicase complex (MCM8/9) that plays an essential role in DNA homologous recombination repair for DNA double-strand break. However, the structural characterization of MCM8/9 for DNA binding/unwinding remains unclear. Here, we report structures of the MCM8/9 complex using cryo-electron microscopy single particle analysis. The structures reveal that MCM8/9 is arranged into a heterohexamer through a three-fold symmetry axis, creating a central channel that accommodates DNA. Multiple characteristic hairpins from the N-terminal oligosaccharide/oligonucleotide (OB) domains of MCM8/9 protrude into the central channel and serve to unwind the duplex DNA. When activated by HROB, the structure of MCM8/9’s N-tier ring converts its symmetry from C3 to C1 with a conformational change that expands the MCM8/9’s trimer interface. Moreover, our structural dynamic analyses revealed that the flexible C-tier ring exhibited rotary motions relative to the N-tier ring, which is required for the unwinding ability of MCM8/9. In summary, our structural and biochemistry study provide a basis for understanding the DNA unwinding mechanism of MCM8/9 helicase in homologous recombination.
Open AccessStructural and mechanistic insights into the MCM8/9 helicase complex
MCM8 and MCM9 form a functional helicase complex (MCM8/9) that plays an essential role in DNA homologous recombination repair for DNA double-strand break. However, the structural characterization of MCM8/9 for DNA binding/unwinding remains unclear. Here, we report structures of the MCM8/9 complex using cryo-electron microscopy single particle analysis. The structures reveal that MCM8/9 is arranged into a heterohexamer through a three-fold symmetry axis, creating a central channel that accommodates DNA. Multiple characteristic hairpins from the N-terminal oligosaccharide/oligonucleotide (OB) domains of MCM8/9 protrude into the central channel and serve to unwind the duplex DNA. When activated by HROB, the structure of MCM8/9’s N-tier ring converts its symmetry from C3 to C1 with a conformational change that expands the MCM8/9’s trimer interface. Moreover, our structural dynamic analyses revealed that the flexible C-tier ring exhibited rotary motions relative to the N-tier ring, which is required for the unwinding ability of MCM8/9. In summary, our structural and biochemistry study provide a basis for understanding the DNA unwinding mechanism of MCM8/9 helicase in homologous recombination.